Association of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427.David F. McDermott, Michael B. Atkins, Georg A. Bjarnason et al.|Journal of Clinical Oncology|2020Cited by 14
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)Toni K. Choueiri, Neeraj Agarwal, Yousef Zakharia et al.|The Oncologist|2021Cited by 10